255 related articles for article (PubMed ID: 16333707)
1. Staging and follow-up of gastrointestinal tumors with PET/CT.
Rosenbaum SJ; Stergar H; Antoch G; Veit P; Bockisch A; Kühl H
Abdom Imaging; 2006; 31(1):25-35. PubMed ID: 16333707
[TBL] [Abstract][Full Text] [Related]
2. [[18F]-FDG-PET in the diagnostics of gastrointestinal tumors].
Buchmann I; Ganten TM; Haberkorn U
Z Gastroenterol; 2008 Apr; 46(4):367-75. PubMed ID: 18393156
[TBL] [Abstract][Full Text] [Related]
3. Value of PET/CT in the management of primary hepatobiliary tumors, part 2.
Sacks A; Peller PJ; Surasi DS; Chatburn L; Mercier G; Subramaniam RM
AJR Am J Roentgenol; 2011 Aug; 197(2):W260-5. PubMed ID: 21785051
[TBL] [Abstract][Full Text] [Related]
4. [Recommendations for clinical practice: use of TEP-FDG in cancer of the esophagus, stomach, colon and rectum, anal canal, large intestine, pancreas and bile ducts, liver and endocrine tumors (digestive system)].
Bourguet P; Planchamp F; Monteil J; Metges JP; Mitry E; Tubiana-Mathieu N
Bull Cancer; 2007 Feb; 94(2):212-8. PubMed ID: 17338096
[No Abstract] [Full Text] [Related]
5. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in digestive system neoplasms].
Bourguet P;
Bull Cancer; 2003 Feb; 90 Spec No():S56-66. PubMed ID: 12739337
[No Abstract] [Full Text] [Related]
6. FDG PET/CT in Pancreatic and Hepatobiliary Carcinomas: Value to Patient Management and Patient Outcomes.
Parikh U; Marcus C; Sarangi R; Taghipour M; Subramaniam RM
PET Clin; 2015 Jul; 10(3):327-43. PubMed ID: 26099670
[TBL] [Abstract][Full Text] [Related]
7. 18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer.
Corvera CU; Blumgart LH; Akhurst T; DeMatteo RP; D'Angelica M; Fong Y; Jarnagin WR
J Am Coll Surg; 2008 Jan; 206(1):57-65. PubMed ID: 18155569
[TBL] [Abstract][Full Text] [Related]
8. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma.
Jadvar H; Henderson RW; Conti PS
J Comput Assist Tomogr; 2007; 31(2):223-8. PubMed ID: 17414758
[TBL] [Abstract][Full Text] [Related]
9. [Application of PET-CT in cancers of the digestive tract].
Li RT; Qian XP; Liu BR
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):81-3. PubMed ID: 17645836
[No Abstract] [Full Text] [Related]
10. [18F]Fluorodeoxyglucose PET/Computed Tomography in Gastrointestinal Malignancies.
Donswijk ML; Hess S; Mulders T; Lam MG
PET Clin; 2014 Oct; 9(4):421-41, v-vi. PubMed ID: 26050945
[TBL] [Abstract][Full Text] [Related]
11. Clinical applications of (18)F-FDG PET in the management of hepatobiliary and pancreatic tumors.
De Gaetano AM; Rufini V; Castaldi P; Gatto AM; Filograna L; Giordano A; Bonomo L
Abdom Imaging; 2012 Dec; 37(6):983-1003. PubMed ID: 22527152
[TBL] [Abstract][Full Text] [Related]
12. Clinical role of 18F-FDG PET-CT in suspected and potentially operable cholangiocarcinoma: a prospective study compared with conventional imaging.
Kim JY; Kim MH; Lee TY; Hwang CY; Kim JS; Yun SC; Lee SS; Seo DW; Lee SK
Am J Gastroenterol; 2008 May; 103(5):1145-51. PubMed ID: 18177454
[TBL] [Abstract][Full Text] [Related]
13. [18F-FDG PET/CT in staging and restaging cholangiocarcinoma].
Notaristefano A; Niccoli Asabella A; Stabile Ianora AA; Merenda N; Moschetta M; Antonica F; Altini C; Ferrari C; Cesarano E; Rubini G
Recenti Prog Med; 2013; 104(7-8):328-35. PubMed ID: 24042402
[TBL] [Abstract][Full Text] [Related]
14. Impact of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma.
Petrowsky H; Wildbrett P; Husarik DB; Hany TF; Tam S; Jochum W; Clavien PA
J Hepatol; 2006 Jul; 45(1):43-50. PubMed ID: 16690156
[TBL] [Abstract][Full Text] [Related]
15. Clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the management of patients with nonpancreatic periampullary neoplasms.
Sperti C; Pasquali C; Fiore V; Bissoli S; Chierichetti F; Liessi G; Pedrazzoli S
Am J Surg; 2006 Jun; 191(6):743-8. PubMed ID: 16720142
[TBL] [Abstract][Full Text] [Related]
16. The role of (18)F-fluorodeoxyglucose positron emission tomography in the diagnosis, staging, and follow-up of cholangiocarcinoma.
Moon CM; Bang S; Chung JB
Surg Oncol; 2011 Mar; 20(1):e10-7. PubMed ID: 19804967
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas.
Moon CM; Bang S; Chung JB; Park SW; Song SY; Yun M; Lee JD
J Gastroenterol Hepatol; 2008 May; 23(5):759-65. PubMed ID: 17931372
[TBL] [Abstract][Full Text] [Related]
18. Primary tumor maximum standardized uptake value measured on 18F-fluorodeoxyglucose positron emission tomography-computed tomography is a prognostic value for survival in bile duct and gallbladder cancer.
Lee JY; Kim HJ; Yim SH; Shin DS; Yu JH; Ju DY; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI
Korean J Gastroenterol; 2013 Oct; 62(4):227-33. PubMed ID: 24162710
[TBL] [Abstract][Full Text] [Related]
19. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
[TBL] [Abstract][Full Text] [Related]
20. Endoscopic ultrasonography.
Ingram M; Arregui ME
Surg Clin North Am; 2004 Aug; 84(4):1035-59, vi. PubMed ID: 15261752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]